Swiss Scientists Reverse Standard Treatment Order for Glioblastoma

Researchers in Switzerland have successfully tested a new approach for treating glioblastoma by administering experimental CAR-T cell therapy before surgery, rather than after. Early results suggest this reversed sequence yields better therapeutic outcomes.